http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11331383-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2bc9273c6f2d7e5216fa347f10ac02e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-12062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-12021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-12034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-12022
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
filingDate 2019-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91b859a50582763df6deb30383ad55f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_384f2e33cfcee496116ab9f34c40a3da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c209da19f50d544d5a37665cabe3813d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cee2cf33aa0e28eeb672df096abe7869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8ae752c691a07bfa77dbee2893a840b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0581dd57c4f5ea505b02414f89095d9
publicationDate 2022-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-11331383-B2
titleOfInvention Attenuated african swine fever virus vaccine
abstract The present invention provides an attenuated African Swine Fever (ASF) virus which lacks a functional version of the following genes:n multigene-family 360 genes 9L, 10L, 11L, 12L, 13L and 14L; and multigene-family 505 genes 1R, 2R, 3R and 4R. nn The invention further provides an attenuated African Swine Fever (ASF) virus which Lacks a functional version of the DP148R gene. The present invention also provides a vaccine comprising such an attenuated virus and its use to prevent ASF. Further, the invention relates to intranasal administration of an attenuated ASF virus.
priorityDate 2014-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008147799-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002086427-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226438542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66584305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16219847
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676152

Total number of triples: 43.